The prestigious US National Institute of Health becomes a returning customer to AcouSort
In 2017, the US National Institute of Health (NIH) purchased the first AcouWash prototype for the cell wash process in a new monitoring method for cancer treatments that they were developing. AcouSort has now received an order from NIH for the new AcouWash 2 system.Since 2017, the NIH researchers have conducted a study comparing AcouWash-based cell wash to a conventional centrifugation-based protocol. The results have been published in Scientific Reports, a journal from the Nature Portfolio, successfully validating the AcouWash for the intended application. The study is part of a larger